Abstracts tagged "Doppler ultrasound and salivary gland"

Abstract Number: 295 • 2019 ACR/ARP Annual Meeting
Assessing the Vascularization of Salivary Glands in Patients with Sjögren’s Syndrome – An OMERACT Ultrasound Group Reliability Exercise
Alojzija Hocevar¹, Sandrine Jousse-Joulin ², Nejc Perko ³, STEPHANIE FINZEL ⁴, PETRA HANOVA ⁵, ANNAMARIA IAGNOCCO ⁶, Nevsun Inanc ⁷, ESPERANZA NAREDO ⁸, WOLFGANG A. SCHMIDT ⁹, Lene Terslev ¹⁰, ALEN ZABOTTI ¹¹, Matija Tomšič ¹² and George A. W. Bruyn ¹³, ¹Department of Rheumatology, University Medical Center Ljubljana, Slovenia, LJUBLJANA, Slovenia, ²Rheumatology Department, Cavale Blanche Hospital and Brest Occidentale University, Brest, France, ³Faculty of electrical engineering, University of Ljubljana, LJUBLJANA, Slovenia, ⁴Department of Rheumatology and Clinical Immunology, University Medical Centre, FREIBURG, Germany, ⁵5Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, PRAGUE, Czech Republic, ⁶Academic Rheumatology Centre, Università degli Studi di Torino, TURIN, Italy, ⁷Marmara University, Faculty of Medicine, Division of Rheumatology, Istanbul, Turkey, ISTANBUL, Turkey, ⁸Rheumatology Department, Joint and Bone Research Unit. Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma, MADRID, Spain, ⁹Medical Center of Rheumatology, Immanuel Krankenhaus Berlin Buch, BERLIN, Germany, ¹⁰Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen, Denmark, ¹¹Department of Medical and Biological Sciences, Rheumatology Clinic, University Hospital Santa Maria della Misericordia, UDINE, Italy, ¹²Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, LJUBLJANA, Slovenia, ¹³Department of Rheumatology, MC Groep Hospitals., Lelystad, Netherlands
Background/Purpose: The vascularization of salivary glands (SG) in Sjögren's syndrome (SS) has not been extensively studied by imaging methods, and currently no agreement exists on…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].